Patents by Inventor Johannes B. M. M. van Bree

Johannes B. M. M. van Bree has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160243203
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: September 23, 2015
    Publication date: August 25, 2016
    Inventors: Johannes B. M. M. van BREE, Edna H. G. VENNEKER, David P. MEEKER
  • Publication number: 20140037611
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: May 3, 2013
    Publication date: February 6, 2014
    Applicant: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B.M.M. van Bree, Edna H.G. Venneker, David P. Meeker
  • Publication number: 20130039901
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: December 21, 2011
    Publication date: February 14, 2013
    Applicant: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B.M.M. van Bree, Edna H.G. Venneker, David P. Meeker
  • Publication number: 20100092449
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: December 9, 2009
    Publication date: April 15, 2010
    Applicant: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B.M.M van Bree, Edna H.G. Venneker, David P. Meeker
  • Patent number: 7655226
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Grant
    Filed: January 30, 2008
    Date of Patent: February 2, 2010
    Assignee: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B. M. M. Van Bree, Edna H. G. Venneker, David P. Meeker
  • Publication number: 20080206223
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: January 30, 2008
    Publication date: August 28, 2008
    Inventors: Johannes B.M.M. Van Bree, Edna H.G. Venneker, David P. Meeker
  • Patent number: 7351410
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: April 1, 2008
    Assignee: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B. M. M. van Bree, Edna H. G. Venneker, David P. Meeker
  • Publication number: 20040081645
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: June 30, 2003
    Publication date: April 29, 2004
    Applicants: Genzyme Corporation, Pharming Intellectual Property B.V.
    Inventors: Johannes B.M.M. Van Bree, Edna H.G. Venneker, David P. Meeker
  • Publication number: 20030007963
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: December 6, 1999
    Publication date: January 9, 2003
    Inventors: JOHANNES B. M. M. VAN BREE, EDNA H. G. VENNEKER, DAVID P. MEEKER